BioSpace 40 Under 40 winners Paull, Zhang let patients with rare disease lead the way at BridgeBio
BridgeBio has produced two young leaders on BioSpace’s 2026 40 Under 40 list. Morgan Paull and Christine Zhang attribute their early success to the company’s unique hub-and-spoke model and a drive to help patients with few treatment options. “It’s very personal,” Paull said.
comments(0)
5-min edit window · permanent after that